AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
10.73
-0.03 (-0.28%)
Sep 3, 2026, 1:48 PM EDT - Market open
AVITA Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Strong Buy" and an average price target of $11.05. The average 1-year stock price forecast is 2.98% higher than the current stock price, while the lowest is $7.96 (-25.82%) and the highest is $14.08 (+31.22%).
Price Target: $11.05 (+2.98%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AVITA Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $12 | Buy | Reiterates | $12 | +11.84% | Aug 28, 2026 |
| BTIG | BTIG | Buy Maintains $7 → $11 | Buy | Maintains | $7 → $11 | +2.52% | Aug 19, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $12 → $14 | Buy | Reiterates | $12 → $14 | +30.48% | Aug 18, 2026 |
| Northland Securities | Northland Securities | Buy Maintains $10 | Buy | Maintains | $10 | -6.80% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
87.25M
from 71.61M
Increased by 21.85%
Revenue Next Year
109.80M
from 87.25M
Increased by 25.83%
EPS This Year
-0.93
from -1.74
EPS Next Year
-0.42
from -0.93
EPS and Forward PE are based on non-GAAP adjusted numbers.